A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. — Stella

Recruiting

Back to Reflux Esophagitis (RE) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Shanghai Changhai Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Large-scale testing

Sponsor

Xuanzhu Biopharmaceutical Co., Ltd.

Enrollment target

~500 participants

Started

July 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov